🇺🇸 FDA
Pipeline program

Intervention D SLS-002

S-21-02 (SLS-002)

Phase 2 small_molecule on_hold

Quick answer

Intervention D SLS-002 for Post Traumatic Stress Disorder is a Phase 2 program (small_molecule) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Adaptive Biotechnologies Corp
Indication
Post Traumatic Stress Disorder
Phase
Phase 2
Modality
small_molecule
Status
on_hold

Clinical trials